杭州默佳生物科技有限公司

FENGHUA Launches New Quantitative Determination Reagents for HBV

PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion

International consensus statement on an update of the classification criteria for definite antiphosp